COVID-19 Vaccine Distribution Confusion Grows As Eligibility Widens
Executive Summary
President-Elect Biden also adds David Kessler and Andy Slavitt to his COVID-19 response team, retains Francis Collins at NIH director.
You may also be interested in...
The More Things Change: The Return Of David Kessler To Capitol Hill
A Senate hearing on the US COVID-19 response recalled Kessler’s tenure as FDA commissioner a quarter century ago – and included some reminders that things have changed.
Biden Vaccination Plan Would Grow Domestic Manufacturing Base
Proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Woodcock To Be Acting US FDA Commissioner, Leaving Agency in Stable, Capable Hands
Agency has been prepping Woodcock for the temporary task but what will happen to her role on Operation Warp Speed remains unclear. The move should give Biden team cushion to confirm a permanent leader of whom a top contender is former senior FDA staffer Joshua Sharfstein, a proponent of drug reforms that may irk manufacturers.